Tongce Medical: Received a regulatory letter from the Shanghai Stock Exchange regarding related-party transactions

LightningPacketLoss · 2026-03-27T16:57:22+00:00

Tongce Medical recently announced that it received a regulatory work letter regarding asset purchases from related parties, involving the listed company, its directors, senior management, intermediary agencies, and other related personnel.

LightningPacketLoss

2026-03-27 16:57:22

Abstract generation in progress

Recently, Tongce Medical announced that the company received a regulatory work letter regarding the purchase of assets from related parties. The subjects involved include the listed company, directors, senior management personnel, controlling shareholders, and actual controllers, as well as intermediary agencies and their related personnel.

(Tongce Medical Announcement)

(Editor: Yang Yan, Lin Chen)

Keywords:

                                                            Medical

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.